Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
van Ingen, J.; Aarnoutse, R. E.; Donald, P. R.; Diacon, A. H.; Dawson, R.; Plemper van Balen, G.; Gillespie, S. H.; Boeree, M. J.
- 期刊名称Clinical Infectious Diseases
- 作者van Ingen, J.; Aarnoutse, R. E.; Donald, P. R.; Diacon, A. H.; Dawson, R.; Plemper van Balen, G.; Gillespie, S. H.; Boeree, M. J.
- 卷第52卷
- 期第9期
- 印刷ISSN1058-4838
- 电子ISSN1537-6591
- 文件大小128.64KB
- 发表时间2011-05-01
- DOI10.1093/cid/cir184